Buy This Document Now

Price: $6.95

100% Money back guaranteed

Document provided by...: www.proquest.com; (Learn more...); ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning.

Are you the owner of this document? Click here for information on why it's on Docstoc.

About This Document: On November 16 ahead of print in Clinical Cancer Research, Park and researchers from the university of North Carolina (Chapel Hill), University of Washington (Seattle), and University Hospital of Lausanne (Switzerland) reported on the development of a series of streptavidin fusion proteins with potential for use in pretargeted radioimmunotherapy (RTT) in non-Hodgkin lymphoma.

Stats: Type:
Acrobat PDF; Size:
1072 kb; Pages:
1; Views:
0; Posted:
01/21/12

Categories: DocStore > Periodicals > Medicine
Tags: The Journal of Nuclear Medicine, Jan 2012, Pretargeted RIT for NHL, Anonymous, News, Lymphomas, Medical research

Embed

Email

Pretargeted RIT for NHL

Document Sample

Pretargeted RIT for NHL

Pr

By registering with docstoc.com you agree to our
privacy policy

Successfully added document to cart!

Successfully added document to cart!